Document:

Cooperation
      Agreement

     

    Party
      A:
      Shaanxi
      Aoxing Pharmaceutical Co., Ltd. 

     

    Party
      B:
      Xianyang Material Medical Institute 

     

    Whereas:
      

     

    1.
      Party
      A commissions Party B to research and develop (the “R&D”)
      the
      traditional Chinese medicine Zhenbaowan Capsule (the “New
      Drug”)
      and
      prepare for the application materials of the New Drug;

     

    2.
      Party
      A is the owner of the New Drug;

     

    3.
      Party
      A and Party B agree to have long-term technical cooperation on R&D of new
      medicine.

     

    Therefore,
      Party A and Party B through mutual negotiations hereby enter into this
      cooperation agreement (the “Agreement”)
      regarding to the issues of New Drug R&D, application and long-term technical
      cooperation according to the following terms and conditions on January 5,
      2007:

     

    Article
      1 R&D of the New Drug

     

    Party
      A
      commissions Party B to research and develop the New Drug, and Party B agrees
      to
      accept the commissioning of researching and developing the New Drug. Party
      B
      shall strictly comply with the technical requirements as set forth in laws
      and
      regulations, such as Drug
      Administration Law of the PRC and
      Administration
      Regulations for Drug Registration,
      and
      report the latest status of the New Drug to Party B in time.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Article
      2 The Ownership of the New Drug

     

    The
      New
      Drug and all the intellectual property rights developed in the R&D process
      of the New Drug shall belong to Party A.

     

    Article
      3 Researching Materials

     

    Party
      B
      shall disclose all samples, formulas, methods, techniques, experiment records,
      documents, drawings and other information (the “Researching
      Materials”)
      regarding the R&D of the New Drug to Party A, and deliver Researching
      Materials to party A or the third party appointed by Party A, according to
      the
      request of Party A. 

     

    Article
      4 Application of New Drug

     

    When
      the
      R&D of the New Drug is completed, Party A shall be the applicant to apply to
      the State Food and Drug Administration (the “SFDA”)
      for
      registering the New Drug, and Party B shall assist Party A with the application.
      Party B shall, as requested by Party A, provide and prepare samples and relevant
      materials in time, revise the aforesaid materials according to the accreditation
      opinion, and deliver them to Party A or a third party appointed by party
      A.

     

    If
      the
      New Drug approving is suspended or terminated due the change of state policy,
      Party A shall take all the relevant financial responsibility.

     

    Article
      5 Expense

     

    5.1
      Expense of R&D of the New Drug

     

    Party
      A
      shall pay the expense of R&D of the New Drug (excluding the application
      expense) to Party B of RMB 180,000, which shall be paid according to following
      terms: 

     

    Party
      A
      shall pay RMB 90,000 to the account designated by Party B on the day that the
      New Drug passes the first materials examination and producing-site examination
      by provincial branch of the SFDA; Party A shall pay the rest RMB 90,000 to
      the
      account designated by Party B on the day that the New Drug passes the new drug
      accreditation by the SFDA and Party A receives the Drug Approval Number of
      the
      New Drug.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    5.2
      Expense of New Drug Application

     

    Party
      A
      shall be responsible for all the expenses rising from the New Drug
      application.

     

    Article
      6 Party B’s Special Warrants

     

    6.1
      Confidentiality 

     

    Party
      B
      covenants to keep the Researching Materials confidential, and not to disclose
      to
      any third party without Party A’s consent.

     

    6.2
      Legal Compliancy of the New Drug R&D

     

    Party
      B
      covenants that the R&D process strictly complies with the relevant laws and
      regulations and industrial practices, and the Researching Materials and results
      are true.

     

    Article
      7 Long-term R&D Cooperation 

     

    Party
      A
      and Party B agree to have long-term cooperation on the R&D of new drug (the
“Project
      Cooperation”).
      All
      the products and relevant intellectual property rights of Project Cooperation
      shall belong to Party A. Party B shall, according to the request of Party A,
      deliver all the Researching Materials regarding the Project Cooperation to
      Party
      A or the third party appointed by Party A.

     

    Party
      B
      shall give necessary assistance when Party A applies for new drug or patent,
      and
      keep the content, products and Researching Materials confidential.

     

    For
      each
      product of Project Cooperation, Party A shall pay certain fee to Party B on
      the
      basis of valuation result. Party A and Party B shall make agreement for the
      details of each co-operation of Project Cooperation besides this
      Agreement.

     

    Article
      8 Breach

     

    Party
      A
      shall be responsible to the loss of New Drug R&D suspending due to Party A’s
      failing to pay the research expense as set forth in this Agreement; Party B
      shall make up the loss of Party A, if the loss is caused by Party B’s breach of
      Article 6 of this Agreement or caused by failing to obtain Drug Approval Number
      due to the technical materials prepared by Party B.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Article
      9 Miscellaneous 

     

    9.1
      Dispute Resolution 

     

    Any
      disputes under the Agreement shall be settled at first through friendly
      consultation between the Parties hereto. In case no settlement can be reached
      through consultation, the dispute shall be brought to the jurisdictional court
      for resolution. 

     

    9.2
      Severability 

     

    The
      invalidity of certain terms and clauses of this Agreement shall not affect
      the
      validity of other terms and clauses.

     

    9.3
      Copies

     

    This
      Agreement is executed in two (2) copies; each Party holds one and each original
      copy has the same legal effect.

     

    (REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK)

      
        

      

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Party
      A: Shaanxi
      Aoxing Pharmaceutical Co., Ltd. (seal) 

     

    Authorized
      Representative (signature): 

     

    

    Party
      B:
      Xianyang
      Material Medical Institute
      (seal) 

     

    Authorized
      Representative (signature):Cooperation
      Agreement

     

    Party
      A:
      Shaanxi
      Science and Technology University

     

    Party
      B:
      Shaanxi
      Aoxing Pharmaceutical Co., Ltd.

     

    Party
      A
      and Party B through mutual negotiations hereby enter into this cooperation
      agreement (the “Agreement”)
      regarding to the issues of intern practice base and technical cooperation
      according to the following terms and conditions on June 13, 2006:

     

    Article
      1 Intern Practice

     

    1.1
      Intern practice base 

     

    Party
      A
      agrees to engage Party B as Party A’s teaching and science researching practice
      base, and Party B agrees to become Party A’s teaching and science researching
      practice base and provide convenience for Party A’s teaching. 

     

    1.2
      Interns

     

    Party
      B
      will send interns (the “Interns”)
      in two
      group a year to practice in Party B; the Interns shall be the official enrolled
      students, teachers, employees or researchers of Party A; the number of Interns
      sent each group shall be between 25 to 30.

     

    1.3
      The schedule and content of intern practice

     

    Party
      A
      shall notify the number, name list and general introduction of the Interns
      to
      Party B in advance; Party B shall have the right to decide on the schedule,
      positions and content of intern practice, in consideration of the Interns’
actual ability and time. Party B shall notify Party A seven days in advance
      after the aforesaid decision is made.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    1.4
      Intern practice fee

     

    The
      commuting, beverage and food expenses of the Interns shall be paid by Party
      A.
      Party B shall pay the intern practice fee of RMB 600 per month for each Intern
      to Party A.

     

    1.5
      Recruitment

     

    Party
      B
      agrees to consider the Interns after their graduation as priority in Party
      B’s
      recruitment.

     

    Article
      2 Technical Cooperation

     

    2.1
      Technical support

     

    Party
      A
      agrees to advise and communicate with Party B on the improving of pharmaceutical
      technique (the “Technical
      Support”).
      Party
      A shall have the right to decide on the content of Technical Support, in
      consideration of the actual need of Party B.

     

    Unless
      otherwise claimed by Party A, the technology, technique, method, information
      and
      other written or unwritten materials (the “Technical
      Information”)
      taught
      by Party A in Technical Support shall be deemed to be authorized to Party B
      for
      use by Party A, without any ownership transfer.

     

    Party
      B
      shall ensure that Technical Information not infringe any third party’s
      intellectual property right. If Party A loses the ownership of Technical
      Information, it shall immediately inform Party B. If Party B suffers any loss
      occurring from the claims by a third party for the infringement of its
      intellectual property right due to the improper notice of Party A, Party A
      shall
      make up such loss. 

     

    Party
      B
      does not have to pay any fee to Party A for the Technical Support and Technical
      Information under this Agreement.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2.2
      R&D of improving pharmaceutical technique

     

    Party
      A
      and Party B agree to cooperate on the R&D of improving pharmaceutical
      technique (the “Project
      Cooperation”).
      All
      the products and relevant intellectual property rights of Project Cooperation
      shall belong to Party B. Party A shall, according to the request of Party B,
      deliver all samples, formulas, methods, techniques, experiment records,
      documents, drawings and other information (the “Researching
      Materials”)
      regarding the Project Cooperation to Party B or the third party appointed by
      Party B.

     

    Party
      A
      shall give necessary assistance when Party B applys for new drug or patent,
      and
      keep the content, products and Researching Materials confidential.

     

    For
      each
      product of Project Cooperation, Party B shall pay certain fee to Party B on
      the
      basis of valuation result. Party A and Party B shall make agreement for the
      details of each co-operation of Project Cooperation besides this
      Agreement.

     

    Article
      3 Rights and Responsibilities of Party A and Party B

     

    3.1
      Party A’s rights

     

    Party
      A
      has right to: (1) request Party B to accept the Interns to practice in Party
      B,
      and send teacher or employees to supervise and advise on practice; (2) decide
      on
      the method and content of Technical Support in consideration of Party B’s
      need.

     

    3.2
      Party A’s Responsibilities

     

    Party
      A
      has responsibilities to (1) notify the number, name list and general
      introduction of the Interns to Party B in advance; (2) ensure that Technical
      Information not infringe any third party’s intellectual property right and
      immediately inform Party B If Party A loses the ownership of Technical
      Information; (3) according to the request of Party B, deliver Researching
      Materials regarding the Project Cooperation to Party B or the third party
      appointed by Party B, give necessary assistance when Party B apply for new
      drug
      or patent, and keep the content, products and Researching Materials
      confidential.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    3.3
      Party B’s rights 

     

    Party
      B
      has right to (1) decide on the schedule, positions and content of intern
      practice, in consideration of the Interns’ actual ability and time; (2) receive
      Technical Support from Party A and use the Technical Information (3) obtain
      the
      ownership of all the products and relevant intellectual property rights of
      Project Cooperation and Researching Materials, and request Party A for giving
      necessary assistance when Party B apply for new drug or patent.

     

    3.4
      Party B’s responsibilities 

     

    Party
      B
      has responsibilities to (1) accept the Interns to practice in Party B, and
      notify the schedule, positions and content of intern practice to Party A seven
      days in advance; (2) keep the Technical Information confidential.

     

    Article
      4 Term of Cooperation

     

    The
      term
      of cooperation under this Agreement is from June 13, 2006 to June 13, 2008.
      This
      Agreement shall be automatically terminated upon the expiration of cooperation
      term.

     

    Article
      5 Copies

     

    This
      Agreement is executed in two (2) copies; each Party holds one and each original
      copy has the same legal effect.

     

    (REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK)

      
        

      

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Party
      A:
      Shaanxi
      Science and Technology University (seal)

     

    Authorized
      Representative (signature): 

     

     

    Party
      B:
      Shaanxi
      Aoxing Pharmaceutical Co., Ltd. (seal) 

     

    Authorized
      Representative (signature):

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]